IJMS | Free Full-Text | Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2
Analysis of the mutation dynamics of SARS-CoV-2 reveals the spread history and emergence of RBD mutant with lower ACE2 binding affinity | bioRxiv
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2 | Nature Structural & Molecular Biology
Frontiers | Plant-Produced Receptor-Binding Domain of SARS-CoV-2 Elicits Potent Neutralizing Responses in Mice and Non-human Primates
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine | Cellular & Molecular Immunology
The proximal origin of SARS-CoV-2 | Nature Medicine
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding - ScienceDirect
Addgene: pcDNA3-SARS-CoV-2-S-RBD-8his
nCoV-2019 Spike Protein Receptor Binding Domain Shares High Amino Acid Identity With a Coronavirus Recovered from a Pangolin Viral Metagenomic Dataset - nCoV-2019 Evolutionary History - Virological
Frontiers | Predictions of the SARS-CoV-2 Omicron Variant (B.1.1.529) Spike Protein Receptor-Binding Domain Structure and Neutralizing Antibody Interactions
Fig 5 | PLOS Biology
Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
Massive sequence perturbation of a small protein | PNAS
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine | Cellular & Molecular Immunology
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor | Nature
Frontiers | SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Potential for developing a SARS-CoV receptor-binding domain (RBD) recombinant protein as a heterologous human vaccine against co
JCI - Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance
Sequence determinants of human-cell entry identified in ACE2-independent bat sarbecoviruses: A combined laboratory and computational network science approach - eBioMedicine
SARS-CoV-2 Research Products & Resources: Novus Biologicals
